We reported that IL-9, aberrantly secreted by leukemic cells isolated from peripheral blood of CLL patients, promotes PD-1 expression in CTLs, thereby strongly affecting their ability to form productive ISs and to kill target cells (44). Here, IL9 is linked to B-cell chronic lymphocytic leukemia.